Skip to content

Total Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$86.48B-6.4%
CTO
Citius Oncology, Inc.CTOR
$100.7M+10.1%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$183.97M-24.2%
Corvus Pharmaceuticals logo
Corvus PharmaceuticalsCRVS
$253.2M+326%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$646.64M+113%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$99.89M-27.9%

Other financials

Income statement

See full
Revenue-
Net income-$7.5M-13.1%
EPS (diluted)-$0.13+13.3%

Balance sheet

See full
Cash & equivalents$6.3M+1.3%
Total debt$456.9K+178%
Total equity$23.2M+135%

Cash flow

See full
Operating cash flow-$4.4M+6.9%
CapEx$48.8K+14.5%
Free cash flow-$4.5M+6.7%

Valuation

See full
Market cap$155.39M+45.8%
Enterprise value$149.54M+52.3%

Returns & leverage

See full
Return on equity-187.2%
Debt / equity0.0×
Current ratio1.2×-1.8×

Where this comes from

Reported directly by TuHURA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: TuHURA Biosciences, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about TuHURA Biosciences, Inc.'s total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TuHURA Biosciences, Inc.'s total assets?
TuHURA Biosciences, Inc. (HURA) reported total assets of $29.7M in Q1 2026.
How has TuHURA Biosciences, Inc.'s total assets changed year-over-year?
TuHURA Biosciences, Inc.'s total assets increased by 102.9% year-over-year, from $14.64M to $29.7M.
What is the long-term trend for TuHURA Biosciences, Inc.'s total assets?
Over 3 years (2022 to 2025), TuHURA Biosciences, Inc.'s total assets has grown at a 40.2% compound annual growth rate (CAGR), from $9.92M to $27.35M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.